One World Products Inc Asset Turnover Ratio (OWPC), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


One World Products Inc   (OWPC)
 

One World Products Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

One World Products Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.03 in the third quarter (Sep 30 2025)

Within sector 195 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2025 compared to the preceding quarter from 3351 to 3815.

Asset Turnover Ratio Definition



OWPC Asset Turnover Ratio (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Asset Change 2306.33 % -60.88 % -86.59 % -30.95 % -90.91 %
Y / Y Revenue Change 3193.74 % -77.51 % 386.17 % - -74.31 %
Asset Turnover Ratio (TTM) 0.03 0.03 0.03 0.02 0.01
OWPC's Total Ranking # 3815 # 3351 # 271 # 3955 # 529
Seq. Asset Change 2826.72 % 817.33 % -63.89 % -75.18 % -52.42 %
Seq. Revenue Change 17618.44 % -79.43 % -24.25 % 19.31 % 20.97 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 196
Healthcare Sector # 539
Overall Market # 3815

Asset Turnover Ratio Statistics
High Average Low
0.03 0.02 0
(Jun 30 2025)   (Dec 31 2023)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Envoy Medical Inc   0.02 $ 0.208  Millions$ 10.001  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.752  Millions$ 36.871  Millions
Prophase Labs Inc   0.02 $ 1.071  Millions$ 55.263  Millions
Prime Medicine Inc   0.02 $ 5.977  Millions$ 322.423  Millions
Fate Therapeutics Inc   0.02 $ 7.137  Millions$ 388.667  Millions
Aim Immunotech Inc   0.02 $ 0.112  Millions$ 6.120  Millions
Crispr Therapeutics Ag  0.02 $ 38.337  Millions$ 2,170.789  Millions
Vivos Inc  0.02 $ 0.046  Millions$ 2.652  Millions
Ataibeckley Inc   0.02 $ 3.018  Millions$ 196.049  Millions
Hcw Biologics Inc   0.02 $ 0.422  Millions$ 27.719  Millions
Vir Biotechnology Inc   0.01 $ 16.860  Millions$ 1,229.631  Millions
Vivosim Labs Inc   0.01 $ 0.140  Millions$ 10.666  Millions
Atrium Therapeutics Inc   0.01 $ 20.868  Millions$ 1,631.526  Millions
Absci Corp  0.01 $ 2.815  Millions$ 225.235  Millions
Nakamoto Inc   0.01 $ 1.980  Millions$ 177.138  Millions
Lyra Therapeutics Inc   0.01 $ 0.600  Millions$ 54.736  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 6.587  Millions
Rallybio Corporation  0.01 $ 0.638  Millions$ 61.189  Millions
Rafael Holdings Inc  0.01 $ 1.029  Millions$ 102.655  Millions
Co diagnostics Inc   0.01 $ 0.508  Millions$ 52.589  Millions
Clene Inc   0.01 $ 0.214  Millions$ 24.272  Millions
Vistagen Therapeutics Inc   0.01 $ 0.721  Millions$ 89.462  Millions
Solana Company  0.01 $ 0.941  Millions$ 122.710  Millions
Dianthus Therapeutics Inc   0.01 $ 3.078  Millions$ 406.527  Millions
Upstream Bio Inc   0.01 $ 2.799  Millions$ 437.401  Millions
Cardiff Oncology Inc   0.01 $ 0.500  Millions$ 80.379  Millions
Precision Biosciences Inc  0.01 $ 0.698  Millions$ 115.809  Millions
Aclarion Inc   0.01 $ 0.067  Millions$ 11.639  Millions
Ainos Inc 0.00 $ 0.113  Millions$ 25.444  Millions
Polomar Health Services, Inc. 0.00 $ 0.037  Millions$ 9.616  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.